London, Tuesday 20th August 2019: Scientists at global biopharmaceutical company MSD and the Francis Crick Institute have started a unique new collaboration to understand the causes of Motor Neurone Disease and identify potential targets for future treatments, co-funded by MSD and the Medical Research Council. This is the first project under a new five-year collaboration agreement, which will see Crick and MSD scientists working together at the Crick to better understand difficult-to-treat di...